Trial Profile
Treatment of olfactory dysfunction in seasonal allergic rhinitis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2012
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 22 Aug 2012 Actual end date (1 Sep 2008) added as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jul 2007 Status change from initiated to recruiting.